Janssen Pharmaceutica N.V.

Contact: Stefan Bouckaert
Web: http://www.janssen.com
Address: Turnhoutseweg 30, Beerse 2340, Belgium
Phone: +1-(800)-526-7736 | Map/Directions >>

Profile: Janssen Pharmaceutica N.V. focuses on Haldol®, Risperdal®, and RisperdalConsta®. Our Invega® Sustenna™ is used for the treatment of schizophrenia. Invega® paliperidone extended-release tablets are approved for acute and maintenance based treatment of schizophrenia. We supply Risperdal® Consta that is used for the treatment of irritability associated with autistic disorder, the treatment of schizophrenia, and the treatment of acute manic or mixed bipolar disorders. Risperdal® risperidone is used to treat autistic disorder including symptoms of aggression, tantrums, and self-injury & quickly changing moods in children and adolescents between the ages 5 to 16 years. These are also used in the treatment of bipolar mania and schizophrenia.

FDA Registration Number: 3002807336
US Agent: Rene Van De Zande / Emergo Global Representation Llc
Phone: +1-(512)-327-9997 Fax: +1-(512)-327-9998 E-Mail:

8 Products/Services (Click for related suppliers)

• Acute Care Physiological Monitor

• Bipolar Instruments

• Medication Injector

• Medication Management

• Mental Health Services

• Pharmaceutical Items

• Pharmaceuticals

• Soft Lens Accessories (FDA Code: LPN / 886.5928)

A soft (hydrophilic) contact lens care product is a device intended for use in the cleaning, rinsing, disinfecting, lubricating/rewetting, or storing of a soft (hydrophilic) contact lens. This includes all solutions and tablets used together with soft (hydrophilic) contact lenses and heat disinfecting units intended to disinfect a soft (hydrophilic) contact lens by means of heat.